vs
Side-by-side financial comparison of MACROGENICS INC (MGNX) and Repay Holdings Corp (RPAY). Click either name above to swap in a different company.
Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $41.2M, roughly 1.9× MACROGENICS INC). On growth, MACROGENICS INC posted the faster year-over-year revenue change (113.0% vs 0.4%). MACROGENICS INC produced more free cash flow last quarter ($42.8M vs $23.2M). Over the past eight quarters, MACROGENICS INC's revenue compounded faster (112.8% CAGR vs -1.3%).
MacroGenics Inc is a clinical-stage biopharmaceutical firm specializing in the research and development of novel immunotherapies for cancer and autoimmune disorders. Its core product pipeline centers on monoclonal antibody-based treatments, with key programs targeting solid tumors and hematological malignancies, supported by partnerships with global pharmaceutical partners.
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
MGNX vs RPAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.2M | $78.6M |
| Net Profit | — | $-140.1M |
| Gross Margin | — | 74.2% |
| Operating Margin | -29.3% | -182.2% |
| Net Margin | — | -178.3% |
| Revenue YoY | 113.0% | 0.4% |
| Net Profit YoY | — | -3304.1% |
| EPS (diluted) | $-0.23 | $-1.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.2M | $78.6M | ||
| Q3 25 | $72.8M | $77.7M | ||
| Q2 25 | $22.2M | $75.6M | ||
| Q1 25 | $13.2M | $77.3M | ||
| Q4 24 | $19.4M | $78.3M | ||
| Q3 24 | $110.7M | $79.1M | ||
| Q2 24 | $10.8M | $74.9M | ||
| Q1 24 | $9.1M | $80.7M |
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $16.8M | $-6.4M | ||
| Q2 25 | $-36.3M | $-102.3M | ||
| Q1 25 | $-41.0M | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $56.3M | $3.2M | ||
| Q2 24 | $-55.7M | $-4.1M | ||
| Q1 24 | $-52.2M | $-5.2M |
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | 98.8% | 76.3% | ||
| Q3 24 | 99.8% | 77.8% | ||
| Q2 24 | 98.4% | 78.2% | ||
| Q1 24 | 97.0% | 76.2% |
| Q4 25 | -29.3% | -182.2% | ||
| Q3 25 | 25.6% | -3.9% | ||
| Q2 25 | -165.3% | -138.7% | ||
| Q1 25 | -323.1% | -4.7% | ||
| Q4 24 | -273.0% | -1.5% | ||
| Q3 24 | 48.9% | -0.9% | ||
| Q2 24 | -538.9% | -4.6% | ||
| Q1 24 | -590.4% | -3.1% |
| Q4 25 | — | -178.3% | ||
| Q3 25 | 23.1% | -8.3% | ||
| Q2 25 | -163.0% | -135.2% | ||
| Q1 25 | -311.1% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | 50.9% | 4.1% | ||
| Q2 24 | -515.6% | -5.4% | ||
| Q1 24 | -573.3% | -6.5% |
| Q4 25 | $-0.23 | $-1.68 | ||
| Q3 25 | $0.27 | $-0.08 | ||
| Q2 25 | $-0.57 | $-1.15 | ||
| Q1 25 | $-0.65 | $-0.09 | ||
| Q4 24 | $-0.24 | $-0.04 | ||
| Q3 24 | $0.90 | $0.03 | ||
| Q2 24 | $-0.89 | $-0.04 | ||
| Q1 24 | $-0.84 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $57.2M | $115.7M |
| Total DebtLower is stronger | — | $280.1M |
| Stockholders' EquityBook value | $55.6M | $484.4M |
| Total Assets | $256.8M | $1.2B |
| Debt / EquityLower = less leverage | — | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.2M | $115.7M | ||
| Q3 25 | $80.1M | $95.7M | ||
| Q2 25 | $130.7M | $162.6M | ||
| Q1 25 | $145.6M | $165.5M | ||
| Q4 24 | $182.8M | $189.5M | ||
| Q3 24 | $179.6M | $168.7M | ||
| Q2 24 | $83.9M | $147.1M | ||
| Q1 24 | $80.4M | $128.3M |
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
| Q4 25 | $55.6M | $484.4M | ||
| Q3 25 | $67.0M | $616.9M | ||
| Q2 25 | $46.6M | $633.7M | ||
| Q1 25 | $79.1M | $755.7M | ||
| Q4 24 | $116.1M | $761.3M | ||
| Q3 24 | $120.1M | $754.7M | ||
| Q2 24 | $57.8M | $815.4M | ||
| Q1 24 | $106.2M | $813.8M |
| Q4 25 | $256.8M | $1.2B | ||
| Q3 25 | $270.8M | $1.3B | ||
| Q2 25 | $245.4M | $1.4B | ||
| Q1 25 | $224.6M | $1.5B | ||
| Q4 24 | $261.7M | $1.6B | ||
| Q3 24 | $264.5M | $1.6B | ||
| Q2 24 | $201.1M | $1.5B | ||
| Q1 24 | $248.3M | $1.5B |
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $43.0M | $23.3M |
| Free Cash FlowOCF − Capex | $42.8M | $23.2M |
| FCF MarginFCF / Revenue | 103.8% | 29.6% |
| Capex IntensityCapex / Revenue | 0.6% | 0.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-83.0M | $90.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.0M | $23.3M | ||
| Q3 25 | $-30.2M | $32.2M | ||
| Q2 25 | $-47.0M | $33.1M | ||
| Q1 25 | $-46.9M | $2.5M | ||
| Q4 24 | $-38.4M | $34.3M | ||
| Q3 24 | $60.2M | $60.1M | ||
| Q2 24 | $-44.5M | $31.0M | ||
| Q1 24 | $-45.6M | $24.8M |
| Q4 25 | $42.8M | $23.2M | ||
| Q3 25 | $-30.6M | $32.1M | ||
| Q2 25 | $-47.7M | $33.0M | ||
| Q1 25 | $-47.4M | $2.4M | ||
| Q4 24 | $-39.0M | $34.0M | ||
| Q3 24 | $59.6M | $59.8M | ||
| Q2 24 | $-45.5M | $30.5M | ||
| Q1 24 | $-47.1M | $24.7M |
| Q4 25 | 103.8% | 29.6% | ||
| Q3 25 | -42.0% | 41.3% | ||
| Q2 25 | -214.5% | 43.6% | ||
| Q1 25 | -359.5% | 3.0% | ||
| Q4 24 | -201.7% | 43.5% | ||
| Q3 24 | 53.8% | 75.6% | ||
| Q2 24 | -421.6% | 40.7% | ||
| Q1 24 | -517.4% | 30.6% |
| Q4 25 | 0.6% | 0.1% | ||
| Q3 25 | 0.6% | 0.2% | ||
| Q2 25 | 3.2% | 0.1% | ||
| Q1 25 | 4.0% | 0.2% | ||
| Q4 24 | 3.2% | 0.3% | ||
| Q3 24 | 0.5% | 0.3% | ||
| Q2 24 | 9.6% | 0.6% | ||
| Q1 24 | 16.0% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | -1.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.07× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MGNX
| Revenue From Collaborative Agreements | $20.3M | 49% |
| Contract Manufacturing | $11.3M | 27% |
| Other | $9.7M | 23% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
